Tooth Extraction Socket Healing in Pediatric Patients Treated with Intravenous Pamidronate

Journal of Pediatrics

Volumn 153, Issue 5, 2008, Pages 719-720

  Chahine, Carol ^a   Cheung, Moira S ^b   Head, Timothy W ^a   Schwartz, Stéphane ^a   Glorieux, Francis H ^b   Rauch, Frank ^b  

^a Faculty of Dentistry   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PAMIDRONIC ACID; ANTIINFLAMMATORY AGENT; BISPHOSPHONIC ACID DERIVATIVE;

ADOLESCENT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BONE NECROSIS; CONTROLLED STUDY; DENTAL CARIES; FEMALE; HUMAN; JAW DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; TOOTH DISEASE; TOOTH EXTRACTION; TOOTH FRACTURE; TREATMENT DURATION; WOUND HEALING; ADULT; CHILD; FOLLOW UP; INFANT; INTRAVENOUS DRUG ADMINISTRATION; PRESCHOOL CHILD;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS; CHILD; CHILD, PRESCHOOL; DIPHOSPHONATES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFUSIONS, INTRAVENOUS; JAW DISEASES; MALE; OSTEONECROSIS; TOOTH EXTRACTION;

EID: 55549112574     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2008.05.003     Document Type: Article

References (12)

1. Rauch F., and Glorieux F.H. Osteogenesis imperfecta. Lancet 363 (2004) 1377-1385
2. Badros A., Weikel D., Salama A., Goloubeva O., Schneider A., Rapoport A., et al. Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors. J Clin Oncol 24 (2006) 945-952
3. Bamias A., Kastritis E., Bamia C., Moulopoulos L.A., Melakopoulos I., Bozas G., et al. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol 23 (2005) 8580-8587
4. Durie B.G., Katz M., and Crowley J. Osteonecrosis of the jaw and bisphosphonates. N Engl J Med 353 (2005) 99-102
5. Mavrokokki T., Cheng A., Stein B., and Goss A. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. J Oral Maxillofac Surg 65 (2007) 415-423
6. Migliorati C.A., Schubert M.M., Peterson D.E., and Seneda L.M. Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy. Cancer 104 (2005) 83-93
7. Weitzman R., Sauter N., Eriksen E.F., Tarassoff P.G., Lacerna L.V., Dias R., et al. Critical review: updated recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in cancer patients, May 2006. Crit Rev Oncol Hematol 62 (2007) 148-152
8. Khosla S., Burr D., Cauley J., Dempster D.W., Ebeling P.R., Felsenberg D., et al. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 22 (2007) 1479-1491
9. American Association of Oral and Maxillofacial Surgeons. Position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 65 (2007) 369-376
10. Grbic J.T., Landesberg R., Lin S.Q., Mesenbrink P., Reid I.R., Leung P.C., et al. Incidence of osteonecrosis of the jaw in women with postmenopausal osteoporosis in the Health Outcomes and Reduced Incidence with Zoledronic Acid Once-Yearly Pivotal Fracture Trial. J Am Dent Assoc 139 (2008) 32-40
11. Mirzai R., Chang C., Greenspan A., and Gershwin M.E. The pathogenesis of osteonecrosis and the relationships to corticosteroids. J Asthma 36 (1999) 77-95
12. Schwartz H.C. Osteonecrosis of the jaws: a complication of cancer chemotherapy. Head Neck Surg 4 (1982) 251-253